Latest News of CDNA
CareDx, Inc (CDNA): Among the Best Organ Transplant and Diagnosis Stocks to Buy According to Hedge Funds?
The article discusses the importance and growth of the organ transplant and diagnosis industry, highlighting CareDx, Inc (NASDAQ:CDNA) as one of the top stocks to consider. The market is expanding due...
Analysts Just Made A Substantial Upgrade To Their CareDx, Inc (NASDAQ:CDNA) Forecasts
Analysts have upgraded CareDx, Inc's revenue and earnings forecasts, leading to a 22% rise in the stock price. Revenue is expected to grow by 9.5% in 2024, with reduced losses....
Earnings Beat: CareDx, Inc (NASDAQ:CDNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
CareDx, Inc (NASDAQ:CDNA) reported strong second-quarter results, exceeding revenue forecasts by 36% with smaller losses than expected. Analysts predict revenue growth and decreased losses in 2024, le...
-
Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics
By Yahoo! Finance | 3 months agoCareDx (CDNA) reported $92.27 million in revenue for the quarter ended June 2024, a 31.3% increase year-over-year. EPS was $0.25 compared to -$0.18 last year....
-
Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 79% gain
By Yahoo! Finance | 3 months agoInvestors can boost returns by selecting market-beating companies like CareDx, Inc (NASDAQ:CDNA), whose share price rose 79% in the last year despite revenue shrinking by 14%. Long-term performance is...